| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/20/2000 | WO2000041679A1 Genetic immunization with co-delivery of nucleic acid and cytokines |
| 07/20/2000 | WO2000041516A2 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | WO2000041508A2 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines |
| 07/20/2000 | WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | WO2000041463A2 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | WO2000031141B1 Humanized antibody specific for surface antigen pre-s1 of hbv and preparation method thereof |
| 07/20/2000 | WO2000020589A3 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |
| 07/20/2000 | WO2000020041A3 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 07/20/2000 | WO2000015767A3 Antigen-presenting cells and their use in therapy |
| 07/20/2000 | WO2000008163A3 Aromatic amino acid decarboxylase proteins of a parasitic helminth, nucleic acid molecules coding them, and uses thereof |
| 07/20/2000 | WO2000004917A3 USE OF HC gp-39 IN IMMUNE DISEASES |
| 07/20/2000 | WO2000004149A3 Compositions and methods for therapy and diagnosis of prostate cancer |
| 07/20/2000 | WO2000002897A9 Delta cleavage products and methods based thereon |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/20/2000 | WO1999053931A9 Tumor cells with increased immunogenicity and uses thereof |
| 07/20/2000 | DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins |
| 07/20/2000 | CA2660344A1 Improved saponin adjuvant compositions and methods relating thereto |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2360584A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | CA2360464A1 Human peptidases |
| 07/20/2000 | CA2359504A1 Novel compounds |
| 07/20/2000 | CA2359492A1 Neisseria meningitidis antigen |
| 07/20/2000 | CA2359486A1 Neisseria meningitidis polypeptide basb052 |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359474A1 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | CA2359111A1 Improved saponin adjuvant compositions and methods relating thereto |
| 07/20/2000 | CA2359110A1 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | CA2358748A1 Reagents and methods useful for detecting diseases of the breast |
| 07/20/2000 | CA2358693A1 Anti-ccr4 antibodies and methods of use therefor |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | CA2357726A1 Chorionic gonadotropin dna vaccines and methods |
| 07/20/2000 | CA2356939A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | CA2356532A1 Noninvasive vascular therapy |
| 07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/19/2000 | EP1020519A1 Minor histocompatibility antigens and their use in the diagnosis and treatment of tumors |
| 07/19/2000 | EP1020516A2 Leptospira vaccine antigens for the prevention of leptospirosis |
| 07/19/2000 | EP1019726A1 Prevention of sudden infant death |
| 07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 07/19/2000 | EP1019494A1 Stimulation of hematopoietic cells in vitro |
| 07/19/2000 | EP1019442A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 07/19/2000 | EP1019439A1 Soluble single-chain t-cell receptor proteins |
| 07/19/2000 | EP1019438A1 Apoptosis-related compounds and their use |
| 07/19/2000 | EP1019437A1 Method for the covalent attachment of polysaccharides to protein molecules |
| 07/19/2000 | EP1019435A1 Amplification of response from expressed recombinant protein |
| 07/19/2000 | EP1019432A1 The ob receptor and methods of diagnosing and treating weight |
| 07/19/2000 | EP1019431A1 Novel rnase p |
| 07/19/2000 | EP1019087A1 Ganglioside immunostimulating complexes and uses thereof |
| 07/19/2000 | EP1019086A1 Altered dna synthesome components as biomarkers for malignancy |
| 07/19/2000 | EP1019085A1 Non-anaphylactic forms of allergens and their use |
| 07/19/2000 | EP1019083A1 Methods and compositions for the selective modification of nucleic acids |
| 07/19/2000 | EP1019082A1 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/19/2000 | EP1019080A2 Modulation of lerk-2-mediated cell adhesion |
| 07/19/2000 | EP1019076A1 Methods and compositions for reducing bacterial tolerance of disinfectants and organic solvents |
| 07/19/2000 | EP1019068A1 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 07/19/2000 | EP1019028A1 $i(CHLAMYDIA) PROTEIN, GENE SEQUENCE AND USES THEREOF |
| 07/19/2000 | EP1019026A2 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 07/19/2000 | EP1019019A1 Buccal, polar and non-polar spray or capsule |
| 07/19/2000 | EP1018877A1 Low molecular weight cell, bone marrow and immune stimulants |
| 07/19/2000 | EP0527815B1 Hepatitis c virus epitopes |
| 07/19/2000 | EP0389570B2 High integrity liposomes and method of preration and use |
| 07/19/2000 | CN1260833A LAG-3 splice variants |
| 07/19/2000 | CN1260723A Oil in water vaccine composition |
| 07/19/2000 | CN1260722A Nerve growth factor as vaccine adjuvant |
| 07/19/2000 | CN1260703A Drug delivery device and method for treating viral and microbial infections and wasting syndromes |
| 07/19/2000 | CN1054609C Monoclonal antibody of human combining mosaic for recognizing epidermal growth factor receptor |
| 07/19/2000 | CN1054544C Polypeptide vaccine for mouth and hoof disease of domestic animal and preparation method |
| 07/18/2000 | US6090923 Immunoglobulin that preferentially binds a human cytotoxin; for the treatment of virus infected or tumor target cells |
| 07/18/2000 | US6090920 Aminoterminal propeptides of typed 1 procollagen |
| 07/18/2000 | US6090914 CTLA4/CD28Ig hybrid fusion proteins and uses thereof |
| 07/18/2000 | US6090791 Method for inducing mucosal immunity |
| 07/18/2000 | US6090789 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof |
| 07/18/2000 | US6090782 Contacting hematopoietic cells with a stem cell proliferation inhibition amount of a peptide or polypeptide having specific amino acid sequence |
| 07/18/2000 | US6090625 Method of increasing the relative number of CD34+ cells in a cell population |
| 07/18/2000 | US6090611 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 07/18/2000 | US6090600 Valyl tRNA synthetase from Staphylococcus aureus |
| 07/18/2000 | US6090587 Prokaryotic expression of MHC proteins |
| 07/18/2000 | US6090586 66 kDa antigen from Borrelia |
| 07/18/2000 | US6090583 Expression system in compatible host cell of a polynucleotide which produces a metalloprotease; diagnosis and treatment of asthma, disorders of leukotriene metabolism; anticarcinogenic agents; antiinflammatory/antidiabetic/antiarthritic agents |
| 07/18/2000 | US6090579 Human SDR2 cDNA clone |
| 07/18/2000 | US6090576 Nucleotide and amino acid sequences; for diagnosis of infections, immunogens, and vaccines especially against otitis media |
| 07/18/2000 | US6090564 Amino acid sequence of human small nuclear ribonucleoprotein protein; for diagnosis, prevention and treatment of systemic lupus erythematosus |
| 07/18/2000 | US6090393 Genetic engineering |
| 07/18/2000 | US6090392 Genetic engineering; culture product |
| 07/18/2000 | US6090391 Recombinant tryptophan mutants of influenza |
| 07/18/2000 | US6090390 Diagnostic test for equine arteritis virus mediated disease |
| 07/18/2000 | US6090388 Peptide composition for prevention and treatment of HIV infection and immune disorders |
| 07/18/2000 | US6090387 Vaccination and methods against diseases resulting from pathogenic responses |
| 07/18/2000 | US6090386 T cell peptides of the CRX JII allergen |
| 07/18/2000 | US6090385 Method of treating cancer |
| 07/18/2000 | US6090382 Human antibodies that bind human TNFα |
| 07/18/2000 | US6090381 Stimulation of an immune response with antibodies labeled with the . .alpha-galactosyl epitope |
| 07/18/2000 | US6090379 Stable pre-occluded virus particle for use in recombinant protein production and pesticides |
| 07/18/2000 | US6090366 Process for the preparation of an organ specific antibodies labeled with technetium-99m |
| 07/18/2000 | CA2162689C Immunotoxins comprising gelonin and an antibody |
| 07/18/2000 | CA2108777C Modified plant viruses as vectors |
| 07/18/2000 | CA2069957C Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes |
| 07/18/2000 | CA2011031C Plasmodium merozoite rhoptries antigen and derivatives thereof |
| 07/18/2000 | CA1341055C Transfectant cell lines which express the major human rhinovirus receptor |
| 07/18/2000 | CA1341053C Polypeptide and protein derivatives and process for their preparation |